Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

149 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of Primary Tumor Location on Second- or Later-Line Treatment With Anti-Epidermal Growth Factor Receptor Antibodies in Patients With Metastatic Colorectal Cancer: A Retrospective Multi-Center Study.
Archwamety A, Teeyapun N, Siripoon T, Poungvarin N, Tanasanvimon S, Sirachainan E, Akewanlop C, Korphaisarn K. Archwamety A, et al. Among authors: poungvarin n. Front Oncol. 2022 Feb 15;12:813009. doi: 10.3389/fonc.2022.813009. eCollection 2022. Front Oncol. 2022. PMID: 35242708 Free PMC article.
High Frequency of KRAS Codon 146 and FBXW7 Mutations in Thai Patients with Stage II-III Colon Cancer.
Korphaisarn K, Pongpaibul A, Roothumnong E, Pongsuktavorn K, Thamlikitkul L, Anekpuritanang T, Poungvarin N, Thongnoppakhun W, Pithukpakorn M. Korphaisarn K, et al. Among authors: poungvarin n. Asian Pac J Cancer Prev. 2019 Aug 1;20(8):2319-2326. doi: 10.31557/APJCP.2019.20.8.2319. Asian Pac J Cancer Prev. 2019. PMID: 31450901 Free PMC article. Clinical Trial.
Co-occurrence CDK4/6 amplification serves as biomarkers of de novo EGFR TKI resistance in sensitizing EGFR mutation non-small cell lung cancer.
Sitthideatphaiboon P, Teerapakpinyo C, Korphaisarn K, Leelayuwatanakul N, Pornpatrananrak N, Poungvarin N, Chantranuwat P, Shuangshoti S, Aporntewan C, Chintanapakdee W, Sriuranpong V, Vinayanuwattikun C. Sitthideatphaiboon P, et al. Among authors: poungvarin n. Sci Rep. 2022 Feb 9;12(1):2167. doi: 10.1038/s41598-022-06239-y. Sci Rep. 2022. PMID: 35140316 Free PMC article.
The KRAS-Mutant Consensus Molecular Subtype 3 Reveals an Immunosuppressive Tumor Microenvironment in Colorectal Cancer.
Tanjak P, Chaiboonchoe A, Suwatthanarak T, Acharayothin O, Thanormjit K, Chanthercrob J, Suwatthanarak T, Wannasuphaphol B, Chumchuen K, Suktitipat B, Sampattavanich S, Korphaisarn K, Pongpaibul A, Poungvarin N, Grove H, Riansuwan W, Trakarnsanga A, Methasate A, Pithukpakorn M, Chinswangwatanakul V. Tanjak P, et al. Among authors: poungvarin n. Cancers (Basel). 2023 Feb 8;15(4):1098. doi: 10.3390/cancers15041098. Cancers (Basel). 2023. PMID: 36831441 Free PMC article.
Dietary pattern and the corresponding gut microbiome in response to immunotherapy in Thai patients with advanced non-small cell lung cancer (NSCLC).
Sitthideatphaiboon P, Somlaw N, Zungsontiporn N, Ouwongprayoon P, Sukswai N, Korphaisarn K, Poungvarin N, Aporntewan C, Hirankarn N, Vinayanuwattikun C, Chanida V. Sitthideatphaiboon P, et al. Among authors: poungvarin n. Sci Rep. 2024 Nov 13;14(1):27791. doi: 10.1038/s41598-024-79339-6. Sci Rep. 2024. PMID: 39537963 Free PMC article.
Establishment and characterization of novel highly aggressive HER2‑positive and triple‑negative breast cancer cell lines.
Thongchot S, Jamjuntra P, Prasopsiri J, Thuwajit P, Sawasdee N, Poungvarin N, Warnnissorn M, Sa-Nguanraksa D, O-Charoenrat P, Yenchitsomanus PT, Thuwajit C. Thongchot S, et al. Among authors: poungvarin n. Oncol Rep. 2021 Dec;46(6):254. doi: 10.3892/or.2021.8205. Epub 2021 Oct 15. Oncol Rep. 2021. PMID: 34651665 Free PMC article.
149 results